News

A brave five-year-old girl whose older sister beat leukaemia has been diagnosed with the same condition.

Imogen Miller, from Aberdeenshire, was diagnosed with Acute Lymphoblastic Leukaemia (ALL) in February after falling ill in December.

The Achilles’ heel of an aggressive type of leukaemia has been discovered by British scientists. It opens the door to developing new drugs for a disease that is notoriously difficult to treat.

There are around 3,100 new cases of acute myeloid leukaemia (AML) every year. Survival rates are currently poor, with around 2,500 people dying each year from AML – that’s 7 people every day.

As part of the global effort, a researcher at Brighton and Sussex Medical School (BSMS), and the universities of Brighton and Sussex, UK, discover the first leukaemia treatment test to quickly and accurately predict how people will respond to standard treatment for the most common type of leukaemia.

Ken Mills, from Queen’s University Belfast, is looking into why some patients with myelodysplastic syndrome (MDS) develop a more aggressive acute myeloid leukaemia (AML). Ken's investigating the impact of DNA repair on disease evolution whilst identifying therapies for both diseases.

Mother Renna, shares the heartbreaking moment her baby girl received a leukaemia diagnosis and the challenges she faced during treatment. 

The team from the UK branch of New York fashion brand 'rag & bone' ran 14km to raise money for leukaemia research, in honour of 14 year old George McCarthey.

Leuka Chairman, Chris Corbin and Leuka Patron, chef Peter Gordon, talk to the Evening Standard about 20 years of foodie fundraising at 'Who's Cooking Dinner?'.

Courtney Wildin, a defender with Coalville Town, was first diagnosed with the blood cancer last year.

The Scottish Medicines Consortium gave the go-ahead to Kymriah but rejected a similar treatment for Scottish adults with blood cancer.

9 year-old Jenson is leukaemia free for a 2nd time after a revolutionary transplant using umbilical cord stem cells.

New research gives hope for bone marrow and stem cell replacement without chemotherapy or whole-body radiation.

Professor Brian J. Druker has been awarded the Prince Mahidol Award 2018 in medicine for his research and contribution to leukaemia treatment.

We're looking for cycling fans up for taking on the Ride London 100 in aid of Leuka's leukaemia research!

The 4th Feb is World Cancer Day - here's how you can help Leuka raise awareness of leukaemia and other blood cancers.

To improve the treatment of chronic lymphocytic leukaemia toward higher efficacy and fewer side effects, scientists are increasingly exploring combination therapies.

Yuvan Thakkar, who has acute lymphoblastic leukaemia (ALL), was given CAR-T therapy after conventional cancer treatments failed.

CAR-T therapy is a completely new type of therapy that uses the immune system to kill cancer cells. It is a personalised treatment, as it uses the patient’s own modified cells to destroy cancer cells. 

Applications for this year's John Goldman Fellowships close on Thursday 31st Jan - so get yours in now!

Thousands of people will benefit as NICE recommends venetoclax with rituximab for adults with relapsed or refractory chronic lymphocytic leukaemia.

A landmark US study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukaemia (CLL).